COMPARISON

2023 VS 2024
 SALES COMPARISON

Q4 2023 Q1 2024
• 69589 S.R • 387490.13 S.R

• D.R EXPENSE 5760 S.R • D.R EXPENSE 10505 S.R

SALES COMPARISON
D.R EXPENSE

35%
Q4 2023
Q1 2024
65%
SALES COMPARISON
S.R

15%

Q1 2024
Q4 2023

85%
 ACCOUNTS COMPARISON

2023 2024
• 17 ACCOUNTS • 31 ACCOUNTS
ACCOUNTS COMPARISON
ACCOUNTS

33% 2023
2024

67%
 NEW ACCOUNTS
• SGH
• NEEM TABUK
• ALAMAL YANBU
• WEQAYA
• MEKNAN
• BETAL
• NEWLIFE
• FAISAL TABUK
• SAMA YANBU
• GAITH ALSHEFAA
• BALSAM MADINA PHARMACY
• LOCINI PHARMACY
 SALES Q1 2024
• TARGET 300000 S.R
• ACHIEVEMENT 387490.13 S.R
• ACHIEVE 129.16 %
 SALES Q1 2024

S.R 387490.13
300000
0 50000 100000 150000 200000 250000 300000 350000 400000 450000

Column1 SALES ACHIEVEMENT SALES TARGET

 COLLECTION Q1 2024
• COLLECTION TARGET 415908 S.R
• COLLECTION ACHIEVEMENT 261870 S.R
• ACHIEVE 62.96%
 COLLECTION Q1 2024

S.R 261870
415908
0 50000 100000 150000 200000 250000 300000 350000 400000 450000

Column1 collection achievement collection target

 COLLECTION ISSUES
Account Name Overdue Collected

DORET ALKADY 146438.5 25000

DORET OKAZ 30000 0

EIN ALHAYAH 19731.25 10000

SULTANA 12270 6500

MAAN 10165 30000

INTERNATIONAL 6815 0

MADINA MEDICAL 27486 25000

 COLLECTION ISSUES
• TOTAL OVER DUE
252950.75 S.R
THANK YOU